Prostate Progress
Who can take part and how to become a volunteer
A welcome message from supporter Stephen Fry
How do I join Prostate Progress?
Prostate Progress: Webinar Series
Webinar 1: An Introduction to Prostate Progress
Prostate Progress: Webinar Series
Webinar 2: Benefits and Risks of Participating
Prostate Progress: Webinar Series
Webinar 3: Signing Up and What Taking Part Actually Involves
Hear from patients about why they joined Prostate Progress and why others should too
Prostate Progress is proud to be the first ‘driver project’ for NHS England’s Data for Research and Development programme. Prostate Progress is powered by NHS Data.
Who funds Prostate Progress?
Prostate Progress is funded by Prostate Cancer Research, sponsorship from the Life Sciences industry, charity partners, trusts and foundations and members of the public via donations.
As part of our ‘Design and Initiation’ phase we received sponsorship from Bayer and Advanced Accelerator Applications (A Novartis Company), as well as in-kind sponsorship from IQVIA.
We will always be open about who funds Prostate Progress.
We will also include a public register on our website of all approved research studies so that participants, the wider public, researchers and policymakers can see how Prostate Progress resources are being used and what studies are being carried out.
Who has reviewed and approved Prostate Progress?
Prostate Progress has been reviewed and approved by the Newcastle & North Tyneside 1 Research Ethics Committee.
Steering Committee
A big thank you to Prostate Progress' Steering Committee (listed below) as well as the many expert and special advisors and dozens of patients who have contributed to this process.
Rakesh | Heer | Chair of Urology at Imperial College London |
Linda | Sharples | Professor of Medical Statistics at the London School of Hygiene & Tropical Medicine |
Dan | Brewer | Professor in Medical Bioinformatics and Genomics at University of East Anglia |
Ann-Marie | Mallon | Programme Lead for Research Data Team – The Alan Turing Institute |
James | Peach | CEO of Human-Centric Drug Discovery |
Rebecca | Cosgriff | Head of Strategy: Data for R&D | NHS Transformation Directorate at NHS England |
Patient | Representative | From Patient Panel |
Patient | Representative | From Patient Panel |
Patient | Representative | From Patient Panel |